Mass spectrometry-based proteomic analysis to characterize cisplatin induced early signaling events in head and neck squamous cell carcinoma

Mass spectrometry-based proteomic analysis to characterize cisplatin induced early signaling events in head and neck squamous cell carcinoma

ABSTRACTCisplatin is the commonly used chemotherapeutic drug in treatment of various cancers. However, development of resistance towards cisplatin results in tumor recurrence. Here, we aim to understand the mechanisms of action of cisplatin and emergence of resistance to cisplatin using mass spectro...

Full description

Bibliographic Details
Main Authors: Ankit P. Jain, Vivek Ghose, Srijon Munshi, Firdous A. Bhat, Gourav Dey, Vishalakshi Nanjappa
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Molecular & Cellular Oncology
Subjects:
Mass spectrometry
drug resistance
cisplatin
head and neck cancer
proteomics
Online Access:https://www.tandfonline.com/doi/10.1080/23723556.2024.2328873

Internet

https://www.tandfonline.com/doi/10.1080/23723556.2024.2328873

Similar Items